This announcement is a separate document:
百诚医药：关于2类改良型新药2022HY052技术转让的公告
Hangzhou Bio-Sincerity Pharma-Tech: Announcement Regarding the Technology Transfer of Type 2 Improved New Drug 2022HY052
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.